| MN | a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt... |
|---|---|
| MRBC | monkey red blood cell; mouse red blood cell |
| PaO2 | partial oxygen tension in arterial blood; partial pressure of oxygen in arterial blood |
| PBF | peripheral blod flow; placental blood flow; pulmonary blood flow |
| PBL | peripheral blood leukocyte; peripheral blood lymphocyte; problem-based learning |
| laky blood | Blood that is undergoing or has undergone laking. See: lake, laky. (05 Mar 2000) |
|---|---|
| fragility of the blood | The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions. (12 Dec 1998) |
| Full Blood Count | <haematology, investigation> The determination of the proper number of red blood cells, white blood cells and platelets are present in the patients blood. Acronym: FBC (16 Dec 1997) |
| Lewis blood group | <haematology> A pair of blood group activities associated with the A, B, H substances. Lewis Lea is a separate gene, whereas Leb arises from the combined activity of the enzymes specified by Le(a) and H genes. (18 Nov 1997) |
| lewis blood-group system | A group of dominantly and independently inherited antigens associated with the abo blood factors. They are glycolipids present in plasma and secretions that may adhere to the erythrocytes. The phenotype le(b) is the result of the interaction of the le gene le(a) with the genes for the abo blood groups. (12 Dec 1998) |
| Loeffler's blood culture medium | A culture medium consisting of beef blood serum, sheep blood serum, and beef bouillon containing peptone, glucose, and sodium chloride; used for the isolation of Corynebacterium diphtheriae. (05 Mar 2000) |
| lutheran blood-group system | A complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor. (12 Dec 1998) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
| adrenal weight factor | A postulated substance of adenohypophysial origin responsible for maintenance of the weight of the adrenal cortex. (05 Mar 2000) |
| adrenocorticotropic releasing factor | Hormone produced by hypothalamus that causes pituitary to secrete adrenocorticotropic hormone. (05 Mar 2000) |
| a-factor | <molecular biology> A protein which is found in the bacterial genus Streptomyces that helps start the production of streptomycin and the process of morphological differentiation. It is used in biotechnology to induce these functions in mutant strains of Streptomyces that cannot produce it themselves. (09 Feb 1998) |
| angiogenesis factor | Substance causing proliferation of new blood vessels. It is found in tissues with high metabolic requirements, such as the retina, and in certain cancers. The factor is also released by hypoxic macrophages at the edges or outer surfaces of wounds and initiates revascularization in wound healing. (12 Dec 1998) |
| animal protein factor | <biochemistry> Member of the water soluble B vitamin group, important in the proper function of the nervous system and important in proper carbohydrate, protein and fat metabolism. (27 Sep 1997) |
| antialopecia factor | A member of the vitamin B complex necessary for growth of yeast and of mice, absence from the diet causes hair loss and dermatitis in mice. (27 Sep 1997) |